Week in Review | International Myeloma Foundation

tardigrade

Week in Review

May 16

Why Resilience Really Matters for Myeloma Patients

ODAC-MRD vote

Week in Review

April 18

FDA Panel Backs MRD Testing to Speed Myeloma Drugs

FDA stamp of approval

Week in Review

April 11

After ODAC Review: FDA Approves Abecma and Carvykti in Earlier Lines of Therapy for Relapsed or Refractory Myeloma Patients

close-up of CAR T-cells

Week in Review

March 21

FDA ODAC Recommends Early Use of Cilta-cel and Ide-cel as Treatments for Relapsed/Refractory Multiple Myeloma

elderly Asian woman getting vaccinated

Week in Review

March 7

Whatever Happened to COVID-19?

patient and care partner conversing

Week in Review

February 22

‘Caregivers Need Care Too’

patient consulting with doctor

Week in Review

February 15

The Path to a Multiple Myeloma Cure: A Doctor's Outlook

Doctor prescribing pills to patient

Week in Review

February 8

In the News: Inflation Reduction Act Brings Drug Savings for Medicare Enrollees; Positive Outcomes from the DREAMM-7 Trial

girl using AI chatbot on screen

Week in Review

January 11

AI 2024: Is a New Wave of Technology Coming?

nurse giving patient injection

Week in Review

December 21

Preparing for and Looking Forward to 2024

ASH 2023

Week in Review

November 16

Prepare for an Intense and Exciting ASH 2023

231026 Dr. Durie blog on Asian Myeloma Summit

Week in Review

October 26

Progress in Asia Helps Myeloma Patients Everywhere

Subscribe to Week in Review

Give Where Most Needed